Literature DB >> 12063821

Epidemiologic and etiologic factors of pancreatic cancer.

Albert B Lowenfels1, Patrick Maisonneuve.   

Abstract

Ranking fourth as a cause of death from cancer for men and women in the United States, pancreatic cancer represents a significant challenge for physicians and surgeons. In addition to the elderly, high-risk groups include blacks, men, smokers, and patients with certain preexisting diseases such as pancreatitis and long-standing diabetes. Various inherited genetic disorders cause approximately 5% to 10% of the total cases of pancreatic cancer. Smoking doubles the risk of pancreatic cancer. Control of smoking offers the best available strategy for reducing the incidence of this disease. Dietary measures to reduce the risk of pancreatic cancer include maintenance of normal body weight and consumption of a well balanced diet with adequate amounts of fruits and vegetables. Chronic pancreatitis caused by heavy alcohol consumption or, rarely, by an underlying inherited disorder is another strong risk factor, but because this benign disease is uncommon, elimination of this underlying cause would have minimal impact on the frequency of pancreatic cancer.

Entities:  

Mesh:

Year:  2002        PMID: 12063821     DOI: 10.1016/s0889-8588(01)00003-x

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  21 in total

1.  Role of BRCA1 and BRCA2 mutations in pancreatic cancer.

Authors:  Julia B Greer; David C Whitcomb
Journal:  Gut       Date:  2006-09-14       Impact factor: 23.059

2.  Genetics and pathology of pancreatic cancer.

Authors:  Jordan M Winter; Anirban Maitra; Charles J Yeo
Journal:  HPB (Oxford)       Date:  2006       Impact factor: 3.647

Review 3.  Lack of association between occupational exposure to diesel exhaust and risk of pancreatic cancer: a systematic evaluation of available data.

Authors:  Paolo Boffetta
Journal:  Int Arch Occup Environ Health       Date:  2013-07-13       Impact factor: 3.015

4.  Frequency of K-ras mutations in pancreatic intraductal neoplasias associated with pancreatic ductal adenocarcinoma and chronic pancreatitis: a meta-analysis.

Authors:  Matthias Löhr; Günter Klöppel; Patrick Maisonneuve; Albert B Lowenfels; Jutta Lüttges
Journal:  Neoplasia       Date:  2005-01       Impact factor: 5.715

5.  Angiolymphatic invasion as a prognostic fator in resected N0 pancreatic adenocarcinoma.

Authors:  Ricardo Vitor Silva de Almeida; Adhemar Monteiro Pacheco; Rodrigo Altenfelder Silva; André de Moricz; Tércio de Campos
Journal:  Arq Bras Cir Dig       Date:  2017 Jan-Mar

Review 6.  The complexities of obesity and diabetes with the development and progression of pancreatic cancer.

Authors:  Bin Bao; Zhiwei Wang; Yiwei Li; Dejuan Kong; Shadan Ali; Sanjeev Banerjee; Aamir Ahmad; Fazlul H Sarkar
Journal:  Biochim Biophys Acta       Date:  2010-12-01

Review 7.  -The advancement of biomarker-based diagnostic tools for ovarian, breast, and pancreatic cancer through the use of urine as an analytical biofluid.

Authors:  Brian M Nolen; Anna E Lokshin
Journal:  Int J Biol Markers       Date:  2011-09-21       Impact factor: 2.659

Review 8.  A starring role for stellate cells in the pancreatic cancer microenvironment.

Authors:  Minoti V Apte; Jeremy S Wilson; Aurelia Lugea; Stephen J Pandol
Journal:  Gastroenterology       Date:  2013-06       Impact factor: 22.682

9.  Assessment of "gene-environment" interaction in cases of familial and sporadic pancreatic cancer.

Authors:  Theresa P Yeo; Ralph H Hruban; Jonathan Brody; Kieran Brune; Sheila Fitzgerald; Charles J Yeo
Journal:  J Gastrointest Surg       Date:  2009-05-21       Impact factor: 3.452

10.  Pancreatitis and pancreatic cancer in two large pooled case-control studies.

Authors:  Paige M Bracci; Furong Wang; Manal M Hassan; Samir Gupta; Donghui Li; Elizabeth A Holly
Journal:  Cancer Causes Control       Date:  2009-11       Impact factor: 2.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.